Literature DB >> 15845487

Identification and characterization of human surfactant protein A binding protein of Mycoplasma pneumoniae.

T R Kannan1, D Provenzano, J R Wright, J B Baseman.   

Abstract

Mycoplasma pneumoniae infections represent a major primary cause of human respiratory diseases, exacerbate other respiratory disorders, and are associated with extrapulmonary pathologies. Cytadherence is a critical step in mycoplasma colonization, aided by a network of mycoplasma adhesins and cytadherence accessory proteins which mediate binding to host cell receptors. Furthermore, the respiratory mucosa is enriched with extracellular matrix components, including surfactant proteins, fibronectin, and mucin, which provide additional in vivo targets for mycoplasma parasitism. In this study we describe interactions between M. pneumoniae and human surfactant protein-A (hSP-A). Initially, we found that viable M. pneumoniae cells bound to immobilized hSP-A in a dose- and calcium (Ca(2+))-dependent manner. Mild trypsin treatment of intact mycoplasmas reduced binding markedly (80 to 90%) implicating a surface-associated mycoplasma protein(s). Using hSP-A-coupled Sepharose affinity chromatography and polyacrylamide gel electrophoresis, we identified a 65-kDa hSP-A binding protein of M. pneumoniae. The presence of Ca(2+) enhanced binding of the 65-kDa protein to hSP-A, which was reduced by the divalent cation-chelating agent, EDTA. The 65-kDa hSP-A binding protein of M. pneumoniae was identified by sequence analysis as a novel protein (MPN372) possessing a putative S1-like subunit of pertussis toxin at the amino terminus (amino acids 1 to 226), with the remaining amino acids (227 to 591) exhibiting no homology with other subunits of pertussis toxin, other known toxins, or any reported proteins. Recombinant MPN372 (MPN372) bound to hSP-A in a dose-dependent manner, which was markedly reduced by preincubation with mouse recombinant MPN372 antisera. Also, adherence of viable M. pneumoniae cells to hSP-A was inhibited by recombinant MPN372 antisera, demonstrating that MPN372, a previously designated hypothetical protein, is surface exposed and mediates mycoplasma attachment to hSP-A.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15845487      PMCID: PMC1087375          DOI: 10.1128/IAI.73.5.2828-2834.2005

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  40 in total

Review 1.  Surfactant proteins a and d and pulmonary host defense.

Authors:  E Crouch; J R Wright
Journal:  Annu Rev Physiol       Date:  2001       Impact factor: 19.318

Review 2.  Surfactant Protein A: regulation of innate and adaptive immune responses in lung inflammation.

Authors:  J R Wright; P Borron; K G Brinker; R J Folz
Journal:  Am J Respir Cell Mol Biol       Date:  2001-05       Impact factor: 6.914

3.  The complete genomic sequence of Mycoplasma penetrans, an intracellular bacterial pathogen in humans.

Authors:  Yuko Sasaki; Jun Ishikawa; Atsushi Yamashita; Kenshiro Oshima; Tsuyoshi Kenri; Keiko Furuya; Chie Yoshino; Atsuko Horino; Tadayoshi Shiba; Tsuguo Sasaki; Masahira Hattori
Journal:  Nucleic Acids Res       Date:  2002-12-01       Impact factor: 16.971

4.  Surfactant protein A binding to cytomegalovirus proteins enhances virus entry into rat lung cells.

Authors:  C Weyer; R Sabat; H Wissel; D H Krüger; P A Stevens; S Prösch
Journal:  Am J Respir Cell Mol Biol       Date:  2000-07       Impact factor: 6.914

5.  Lung surfactant protein A provides a route of entry for respiratory syncytial virus into host cells.

Authors:  T P Hickling; R Malhotra; H Bright; W McDowell; E D Blair; R B Sim
Journal:  Viral Immunol       Date:  2000       Impact factor: 2.257

6.  Effects of surfactant protein A and NaCl concentration on the uptake of Pseudomonas aeruginosa by THP-1 cells.

Authors:  K R Khubchandani; R E Oberley; J M Snyder
Journal:  Am J Respir Cell Mol Biol       Date:  2001-12       Impact factor: 6.914

7.  Elongation factor Tu and E1 beta subunit of pyruvate dehydrogenase complex act as fibronectin binding proteins in Mycoplasma pneumoniae.

Authors:  Shatha F Dallo; T R Kannan; Mark W Blaylock; Joel B Baseman
Journal:  Mol Microbiol       Date:  2002-11       Impact factor: 3.501

Review 8.  Surfactant protein A (SP-A): the alveolus and beyond.

Authors:  K R Khubchandani; J M Snyder
Journal:  FASEB J       Date:  2001-01       Impact factor: 5.191

9.  Intracellular DNA replication and long-term survival of pathogenic mycoplasmas.

Authors:  S F Dallo; J B Baseman
Journal:  Microb Pathog       Date:  2000-11       Impact factor: 3.738

10.  Surface localized glyceraldehyde-3-phosphate dehydrogenase of Mycoplasma genitalium binds mucin.

Authors:  René A Alvarez; Mark W Blaylock; Joel B Baseman
Journal:  Mol Microbiol       Date:  2003-06       Impact factor: 3.501

View more
  56 in total

1.  Fatal outcomes in family transmission of Mycoplasma pneumoniae.

Authors:  T R Kannan; R D Hardy; J J Coalson; D C Cavuoti; J D Siegel; M Cagle; O Musatovova; C Herrera; J B Baseman
Journal:  Clin Infect Dis       Date:  2011-11-03       Impact factor: 9.079

2.  Synthesis and distribution of CARDS toxin during Mycoplasma pneumoniae infection in a murine model.

Authors:  T R Kannan; Jacqueline J Coalson; Marianna Cagle; Oxana Musatovova; R Doug Hardy; Joel B Baseman
Journal:  J Infect Dis       Date:  2011-09-28       Impact factor: 5.226

3.  Mycoplasma pneumoniae CARDS toxin induces pulmonary eosinophilic and lymphocytic inflammation.

Authors:  Jorge L Medina; Jacqueline J Coalson; Edward G Brooks; Vicki T Winter; Adriana Chaparro; Molly F R Principe; Thirumalai R Kannan; Joel B Baseman; Peter H Dube
Journal:  Am J Respir Cell Mol Biol       Date:  2012-01-26       Impact factor: 6.914

4.  Protein P200 is dispensable for Mycoplasma pneumoniae hemadsorption but not gliding motility or colonization of differentiated bronchial epithelium.

Authors:  Jarrat L Jordan; How-Yi Chang; Mitchell F Balish; Lynley S Holt; Stephanie R Bose; Benjamin M Hasselbring; Robert H Waldo; Thomas M Krunkosky; Duncan C Krause
Journal:  Infect Immun       Date:  2006-10-16       Impact factor: 3.441

5.  Crystallization of community-acquired respiratory distress syndrome toxin from Mycoplasma pneumoniae.

Authors:  Olga N Pakhomova; Alexander B Taylor; Argentina Becker; Stephen P Holloway; T R Kannan; Joel B Baseman; P John Hart
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2010-02-24

6.  Surfactant protein A is defective in abrogating inflammation in asthma.

Authors:  Ying Wang; Dennis R Voelker; Njira L Lugogo; Guirong Wang; Joanna Floros; Jennifer L Ingram; Hong Wei Chu; Tony D Church; Pitchaimani Kandasamy; Daniel Fertel; Jo Rae Wright; Monica Kraft
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-07-22       Impact factor: 5.464

Review 7.  New insights into the pathogenesis and detection of Mycoplasma pneumoniae infections.

Authors:  Ken B Waites; Mitchell F Balish; T Prescott Atkinson
Journal:  Future Microbiol       Date:  2008-12       Impact factor: 3.165

8.  Surfactant Protein-A Protects against IL-13-Induced Inflammation in Asthma.

Authors:  Dave Francisco; Ying Wang; Michelle Conway; Audriana N Hurbon; Alane B C Dy; Kenneth J Addison; Hong W Chu; Dennis R Voelker; Julie G Ledford; Monica Kraft
Journal:  J Immunol       Date:  2020-04-03       Impact factor: 5.422

Review 9.  Pulmonary surfactant: an immunological perspective.

Authors:  Zissis C Chroneos; Zvjezdana Sever-Chroneos; Virginia L Shepherd
Journal:  Cell Physiol Biochem       Date:  2009-12-22

10.  Analysis of pulmonary inflammation and function in the mouse and baboon after exposure to Mycoplasma pneumoniae CARDS toxin.

Authors:  R Doug Hardy; Jacqueline J Coalson; Jay Peters; Adriana Chaparro; Chonnamet Techasaensiri; Angelene M Cantwell; T R Kannan; Joel B Baseman; Peter H Dube
Journal:  PLoS One       Date:  2009-10-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.